Viewing nowNerostin Tablet (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
SS Pharm Co., Ltd.

MFDS item code 201603999 · Approved 2016.06.27 · Insurance code 663300850
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct to diet for patients with primary hypercholesterolemia and mixed hyperlipidemia who are difficult to control with diet and exercise. It can also be used in conjunction with other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. It helps lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It is also used as a dietary supplement in some pediatric patients with high LDL cholesterol levels and cardiovascular disease risk factors. It also applies to the treatment of primary dysbetalipoproteinemia. Lastly, it is useful for middle-aged patients with high sensitivity C-reactive protein levels and additional cardiovascular disease risk factors in reducing the risks of stroke, myocardial infarction, and arterial revascularization procedures. This medication is effectively used in reducing hyperlipidemia and cardiovascular disease risk.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, regardless of food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17) Ages 10 to 17: 5 milligrams to 20 milligrams once daily (there are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Safety and efficacy in children under 10 years of age have not been established.
This drug should not be used in certain patients. For example, it should not be administered to patients who are allergic to any component of this drug, patients with severely impaired liver function, patients with muscle diseases, and patients with severe kidney dysfunction. It should also not be given to pregnant or nursing women, or to women of childbearing age who do not use appropriate contraception. For women of childbearing age, it should only be used if the pregnancy possibility is low and after adequately explaining the risk to the fetus. This drug is contraindicated in patients with a high risk of muscle-related side effects. For example, patients with moderate to severe renal impairment, hypothyroidism, a family history of muscle diseases, alcohol dependence, and those receiving certain drug combinations should avoid high doses. It contains lactose, so patients with lactose intolerance or related genetic disorders should not use it. This drug can affect liver function, so patients with a history of excessive drinking or liver disease must undergo regular liver function tests before and during administration. If symptoms such as muscle pain, weakness, or cramps occur, notify healthcare professionals immediately, and if needed, conduct blood tests to check for muscle damage. If muscle enzyme levels significantly increase, the use of the drug should be discontinued. This drug can rarely cause serious skin reactions, liver damage, kidney issues, and neurological abnormalities. If such symptoms occur, discontinue the drug immediately and consult a doctor. There may be interactions when combined with other medications, so it is essential to inform about any medications currently being taken, especially when taking specific antivirals, immunosuppressants, antibiotics, or fibric acid derivatives. Women who are pregnant or planning to become pregnant should not take this drug, and nursing mothers should avoid its use. In the case of overdose, there is no specific antidote, and treatment based on symptoms and liver and muscle function tests is necessary. Dizziness may occur when driving or operating machinery, so caution is advised. Finally, this drug may present higher blood concentration levels in Asians, requiring dose adjustments. Therefore, it is crucial to take it exactly as directed by a physician and to consult immediately if any unusual symptoms occur.
Angioedema, hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms, drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, paraesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
Store this drug in a closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablets
28 tablets/PTP packaging, 30 tablets/PTP packaging
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
SS Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.